BIO · CIK 12208
What Bio-Rad Laboratories, Inc. told the SEC could break it.
Bio-Rad's disclosures sit on both the demand and supply sides of a life-science tools business. On demand, many of its Life Science customers rely on government grants and research contracts, and in 2025 the US government proposed cutting federal funding to some of those customers, pressuring demand. On supply, while it multi-sources most inputs, in certain cases it depends on a sole supplier for components and materials, where regulatory constraints make replacement difficult. Layered over its globally sourced supply chain, new and increased US tariffs and foreign countermeasures add cost and supply uncertainty.
3 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- research customers dependent on U.S. government grant fundingmedium
Many Life Science customers depend on government grants/research contracts; in 2025 the U.S. government proposed federal funding reductions to some of Bio-Rad's customers, pressuring demand.
“In 2025, the United States government proposed reductions of federal funding to some institutions and companies that are our customers.”
SEC filing →As of 2026
Sole-source dependency
- sole-supplier components and materialsmedium
Although most materials/components are multi-sourced, in certain instances Bio-Rad acquires components and materials from a sole supplier, with regulatory constraints limiting replacement sourcing.
“Further, while we seek to diversify our sources of components and materials, in certain instances we acquire components and materials from a sole supplier.”
SEC filing →As of 2026
Regulatory & policy
- U.S. tariffs and foreign countermeasureslow
New and increased U.S. tariffs plus foreign countermeasures add cost and supply uncertainty for Bio-Rad's globally sourced components and materials.
“The United States continues to announce new tariffs and significant increases to existing tariffs. Other countries continue to respond with countermeasures.”
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch